×

Market too optimistic on growth in diabetes market: Polar Capital

4:10 AM ET Fri, 5 Aug 2016

Daniel Mahony, fund manager at Polar Capital, takes a look at Novo Nordisk’s latest earnings, while discussing their main competitors and the state of the pharmaceutical world.